Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Rheumatoid Arthritis

Free Subscription Articles published in Rheumatol Int Retrieve available abstracts of 206 articles: HTML format

Single Articles

November 2026
1. TAKANASHI S, Kaneko Y, Kawahito Y, Kida T, et al
   Perspectives of rheumatologists on the management of late-onset rheumatoid arthritis: a nationwide cross-sectional survey.
   Rheumatol Int. 2026;46:311.
   PubMed     Abstract available
   
   
   
2. EKEN A, Ayan G, Yazgan BF, Kart Bayram GS, et al
   Frequency of difficult-to-treat rheumatoid arthritis and associated factors at b/tsDMARD initiation in a tertiary referral center: a cross-sectional study.
   Rheumatol Int. 2026;46:310.
   PubMed     Abstract available
   
   
   
3. CHEN G, Peng JM
   The potential influence of fibromyalgia on disease activity assessment and baricitinib retention in rheumatoid arthritis.
   Rheumatol Int. 2026;46:309.
   PubMed    
   
   
   
4. LUCKI M, Grygiel-Gorniak B, Lucka E, Lesiak M, et al
   Mitral valve disease in rheumatic heart disease, systemic lupus erythematosus, antiphospholipid syndrome, and rheumatoid Arthritis.
   Rheumatol Int. 2026;46:304.
   PubMed     Abstract available
   
   
   
5. ESTRADA PF, Cavalcante MRN, de Souza Santos I, Brunoni AR, et al
   Incident generalized anxiety and common mental disorders in rheumatoid arthritis: a 12-year case-cohort analysis from ELSA-Brasil.
   Rheumatol Int. 2026;46:302.
   PubMed     Abstract available
   
   
   October 2026
6. KARIGOWDA L, Wong V, Tran A, Lau W, et al
   Severe ARDS and secondary haemophagocytic lymphohistiocytosis complicating a flare of adult-onset Still's disease: a case-based review.
   Rheumatol Int. 2026;46:299.
   PubMed     Abstract available
   
   
   
7. APAYDIN H, Deniz R, Yilmaz GC, Erdogan M, et al
   Safety, tissue adequacy, and diagnostic contribution of ultrasound-guided synovial biopsy: a retrospective multicenter observational study in a heterogeneous rheumatology cohort.
   Rheumatol Int. 2026;46:295.
   PubMed     Abstract available
   
   
   
8. GARCIA-SALINAS R, Chavez-Lopez M, Gomez RA, Otaola M, et al
   Divergent approaches to rheumatoid arthritis-associated interstitial lung disease: a comparative analysis of international clinical practice guidelines.
   Rheumatol Int. 2026;46:291.
   PubMed     Abstract available
   
   
   
9. SUKARA G, Dinjar Kujundzic P, Madir A, Pitesa Kosutic I, et al
   Tocilizumab for active rheumatoid arthritis in a patient with concomitant primary biliary cholangitis: a case based review.
   Rheumatol Int. 2026;46:292.
   PubMed     Abstract available
   
   
   
10. FLOURI I, Bertsias A, Zoupidou K, Koutsianas C, et al
    Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients.
    Rheumatol Int. 2026;46:276.
    PubMed     Abstract available
    
    
    
11. ZINTZIOVAS N, Karakosta A, Voulgari P, Stefanakis G, et al
    Cannabinoids for pain management in rheumatoid arthritis: a scoping review of clinical evidence and mechanisms.
    Rheumatol Int. 2026;46:275.
    PubMed     Abstract available
    
    
    September 2026
12. FEDKOV D, Yevstifeiev D, Iaremenko O, Dopfer-Jablonka A, et al
    Longitudinal fatigue outcomes and prediction in inflammatory arthritis: a real-world digital cohort study.
    Rheumatol Int. 2026;46:270.
    PubMed     Abstract available
    
    
    
13. KORN TF, Manzano GS, Clark MW, Bhattacharyya S, et al
    Pregnancy outcomes in women with rheumatologic diseases and neurologic involvement.
    Rheumatol Int. 2026;46:265.
    PubMed     Abstract available
    
    
    
14. KHOJAKULOVA U, Yessirkepov M, Nurmashev B, Zimba O, et al
    Handgrip strength relative to age- and sex-specific reference values in hospitalised patients with highly active rheumatoid arthritis: a single-centre cross-sectional study.
    Rheumatol Int. 2026;46:252.
    PubMed     Abstract available
    
    
    August 2026
15. ZINTZIOVAS N, Drosos GA, Yerolatsite M, Goussia A, et al
    Pulmonary amyloidosis, gastric MALT lymphoma, and multiple sclerosis in a patient with Sjogren's disease: a case report and review of the literature.
    Rheumatol Int. 2026;46:244.
    PubMed     Abstract available
    
    
    
16. KAMINSKA M, Chrobak M, Silva LSA, de Oliveira YGP, et al
    Anti-gingipain antibodies and ACE1 activity in rheumatoid arthritis: associations with disease activity and cardiovascular comorbidity in a cross-sectional study.
    Rheumatol Int. 2026;46:243.
    PubMed     Abstract available
    
    
    
17. EROL K, Akyildiz Tezcan E, Bas Bilen N, Gurbuz C, et al
    Medication adherence is associated with the necessity-concern differential in newly diagnosed primary Sjogren disease: a prospective observational cohort study.
    Rheumatol Int. 2026;46:242.
    PubMed     Abstract available
    
    
    
18. BORRAS-BLASCO J, Valcuende-Rosique A, Cornejo-Uixeda S
    Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.
    Rheumatol Int. 2026;46:238.
    PubMed    
    
    
    
19. LIU S, Jiang M, Zhang M, Li Z, et al
    Association between disease activity, arterial stiffness, and 10-year cardiovascular risk in patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2026;46:237.
    PubMed     Abstract available
    
    
    
20. LI J, Li S, Gesang Y, Wang W, et al
    Low albumin-to-globulin ratio is associated with interstitial lung disease in primary Sjogren's syndrome: a single-center retrospective cohort study with propensity score matching.
    Rheumatol Int. 2026;46:241.
    PubMed     Abstract available
    
    
    
21. ROMANA P, Labreche AD, Numeric P, Deligny C, et al
    Ten-year incidence and heart failure dominance of hospitalized cardiovascular events in rheumatoid arthritis: a hospital-based cohort study from Martinique.
    Rheumatol Int. 2026;46:231.
    PubMed     Abstract available
    
    
    
22. GWOZDZ-BROCZKOWSKA A
    Fatigue beyond inflammation in inflammatory rheumatic diseases: a narrative review and treatable-traits framework.
    Rheumatol Int. 2026;46:232.
    PubMed     Abstract available
    
    
    
23. LEWANDOWSKA-POLAK A, Brzezinska O, Krawiec P, Skalska U, et al
    Diagnostic methods of rheumatoid arthritis-associated interstitial lung disease: a systematic review.
    Rheumatol Int. 2026;46:229.
    PubMed     Abstract available
    
    
    July 2026
24. SAIDI AN, Burggraaf B, van der Lelij AJ, van der Zwan-van Beek E, et al
    LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial.
    Rheumatol Int. 2026;46:222.
    PubMed     Abstract available
    
    
    
25. KEBKE M, Adolfsson E, Stromberg J, Dehlin M, et al
    Rapid pain response following intra-articular steroid injections in rheumatoid arthritis finger joints: a prospective study with daily patient self-assessment.
    Rheumatol Int. 2026;46:223.
    PubMed     Abstract available
    
    
    
26. RABELLO LC, Miranda VC, de Paula TS, Ferreira Silva IA, et al
    Anti-Toxocara canis seroreactivity across autoimmune rheumatic diseases with exploratory IgG4 and eosinophil-associated signals in systemic lupus erythematosus: a cross-sectional case-control study.
    Rheumatol Int. 2026;46:212.
    PubMed     Abstract available
    
    
    
27. ISIK BY, Babayigit A, Dogan HO, Sahin A, et al
    Endoplasmic reticulum stress and apoptosis-associated biomarkers in rheumatoid arthritis: an exploratory case-control study.
    Rheumatol Int. 2026;46:202.
    PubMed     Abstract available
    
    
    
28. SCHNEIDER L, Henes JC, Saur SJ
    Pre-referral laboratory completeness and diagnostic yield in an early arthritis clinic: a retrospective single-centre analysis.
    Rheumatol Int. 2026;46:187.
    PubMed     Abstract available
    
    
    
29. ARMAGHANI DJ, Angeloudi E, Gandomi AH, Anyfanti P, et al
    Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based study.
    Rheumatol Int. 2026;46:185.
    PubMed     Abstract available
    
    
    
30. PRANDO BC, Albano TM, Dos Santos GB, Goncalves GV, et al
    Health education needs of the Brazilian population with rheumatoid arthritis: mixed-methods cross-sectional study.
    Rheumatol Int. 2026;46:181.
    PubMed     Abstract available
    
    
    June 2026
31. KOPRULUOGLU M, Naz I, Alp G, Solmaz D, et al
    Investigation of factors affecting exercise perception in women with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2026;46:176.
    PubMed     Abstract available
    
    
    
32. CHEN H, Yan K, Cai J, Chen X, et al
    Chronic relapsing aseptic meningoencephalitis in Sjogren's disease and cryoglobulinemia successfully treated with intrathecal dexamethasone: a case-based review.
    Rheumatol Int. 2026;46:177.
    PubMed     Abstract available
    
    
    
33. TOLIOPOULOS IK, Bougiouklis D, Papagiannakis P, Stavridis C, et al
    Distinct immunological signatures in autoimmunity: a multi-plex analysis for the differential diagnosis of established and undifferentiated autoimmune diseases (a cross-sectional pilot study).
    Rheumatol Int. 2026;46:174.
    PubMed     Abstract available
    
    
    
34. HUANG Y, Agarwal SK
    Natural language processing to enhance rheumatoid arthritis care in clinical studies: a scoping review of applications, data, approaches, challenges and future directions.
    Rheumatol Int. 2026;46:164.
    PubMed     Abstract available
    
    
    
35. TRUIJEN SPM, Boonen A, Ramiro S, van Onna M, et al
    Physical function in older people with rheumatoid arthritis and population controls: a cross-sectional study of self-reported and performance-based measures.
    Rheumatol Int. 2026;46:155.
    PubMed     Abstract available
    
    
    
36. YERLANOVA D, Zimba O, Makhanbetkulova D, Nurmashev B, et al
    Healthcare professionals' knowledge and views on unmet needs in prevention of infectious comorbidities in pregnant women with inflammatory rheumatic diseases.
    Rheumatol Int. 2026;46:154.
    PubMed     Abstract available
    
    
    
37. ALNAIMAT F, Ayoub M, Abdelrahim B, Khalil L, et al
    Patterns of referral and histopathological interpretation of minor salivary gland biopsy in suspected Sjogren's disease: a single-center experience.
    Rheumatol Int. 2026;46:151.
    PubMed     Abstract available
    
    
    
38. ALKHATIB A, Al-Kofahi M, Abumuhfouz M, Elliott DRF, et al
    Hydroxychloroquine-associated cardiomyopathy with nondiagnostic noninvasive evaluation: diagnostic value of endomyocardial biopsy in a case-based review.
    Rheumatol Int. 2026;46:152.
    PubMed     Abstract available
    
    
    
39. BEDAIWI M
    Toward causal artificial intelligence for biologic treatment response in rheumatoid arthritis: current evidence and future directions.
    Rheumatol Int. 2026;46:149.
    PubMed     Abstract available
    
    
    
40. YILMAZ GC, Apaydin H, Inal RS, Gencoglu ATT, et al
    Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjogren disease: a single-center cross-sectional study.
    Rheumatol Int. 2026;46:148.
    PubMed     Abstract available
    
    
    
41. DUCH KS, Alkattan M, Holm TAM, Pakyanathan P, et al
    Glucocorticoid use among patients with rheumatoid arthritis during the first year of treatment-a cohort study.
    Rheumatol Int. 2026;46:144.
    PubMed     Abstract available
    
    
    
42. SUZUKI K, Akiyama M, Saito K, Kaneko Y, et al
    Correction: Diagnostic and therapeutic challenges in concomitant axial spondyloarthritis and rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2026;46:143.
    PubMed    
    
    
    
43. KOLASINSKA M, Wilk M, Polak D, Siwek M, et al
    Underrecognized depressive and anxiety symptoms in inflammatory arthritis: implications for systematic screening using PHQ-9 and GAD-7.
    Rheumatol Int. 2026;46:141.
    PubMed     Abstract available
    
    
    
44. AYTEKI?N KANADLI K, Olgun N, Sazak Y
    Experiences of rheumatoid arthritis patients with digital health technologies in self-management: a qualitative study.
    Rheumatol Int. 2026;46:133.
    PubMed     Abstract available
    
    
    
45. MATSUMOTO H, Yamamoto S, Yoshida S, Shimojima Y, et al
    Methodological considerations in interpreting short-term functional gains after structured hand massage in rheumatoid arthritis.
    Rheumatol Int. 2026;46:135.
    PubMed    
    
    
    
46. MANAVI D, Tunks A, Diment W, Bortoluzzi A, et al
    Fibromyalgia in systemic autoimmune rheumatic diseases: a mixed-methods study of patient and clinician perspectives.
    Rheumatol Int. 2026;46:128.
    PubMed     Abstract available
    
    
    
47. RUSINOVICH-LOVGACH O, Plaza Z, Andreu JL, Rosas J, et al
    Major adverse cardiovascular events in Sjogren's disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort.
    Rheumatol Int. 2026;46:122.
    PubMed     Abstract available
    
    
    May 2026
48. TATAR OD, Kilic L, Kalyoncu U, Ertenli AI, et al
    Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study.
    Rheumatol Int. 2026;46:117.
    PubMed     Abstract available
    
    
    
49. DILEK G, Unan MK, Gokcen N, Uzun E, et al
    Central sensitization in rheumatoid arthritis and psoriatic arthritis is associated with symptom burden than inflammatory activity: a cross-sectional study.
    Rheumatol Int. 2026;46:113.
    PubMed     Abstract available
    
    
    
50. ANSARI S, Kanika
    Outcome measures and Clinical Implications of Hand Massage in Rheumatoid Arthritis.
    Rheumatol Int. 2026;46:111.
    PubMed    
    
    
    
51. VUKSIC J, Kustic D
    Imaging correlates of disease activity and patient-reported symptoms in primary Sjogren's disease: an ultrasonographic and scintigraphic study.
    Rheumatol Int. 2026;46:100.
    PubMed     Abstract available
    
    
    
52. ADELEYE E, Abushama S, Jeyakumar A, Dubey S, et al
    Still's disease in pregnancy complicated by anakinra-related hepatotoxicity and rescued by intravenous immunoglobulin: a case-based review.
    Rheumatol Int. 2026;46:98.
    PubMed     Abstract available
    
    
    
53. SUZUKI K, Akiyama M, Saito K, Kaneko Y, et al
    Diagnostic and therapeutic challenges in concomitant axial spondyloarthritis and rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2026;46:91.
    PubMed     Abstract available
    
    
    
54. ZIADE N, Hmamouchi I, Moussallem M, Salameh BL, et al
    Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort.
    Rheumatol Int. 2026;46:86.
    PubMed     Abstract available
    
    
    April 2026
55. FEDORCHENKO Y, Khojakulova U, Zimba O, Kocyigit BF, et al
    Handgrip strength testing in rheumatic diseases.
    Rheumatol Int. 2026;46:82.
    PubMed     Abstract available
    
    
    
56. FEDKOV D, Yevstifeiev D, Iaremenko O, Koliadenko D, et al
    Baseline pain, fatigue, and sleep quality predict 12-week pain improvement in inflammatory arthritis: retrospective real-world analysis of a digital health application cohort.
    Rheumatol Int. 2026;46:77.
    PubMed     Abstract available
    
    
    
57. KHOJAKULOVA U, Ozturk GY, Okyar B, Zimba O, et al
    The effect of structured hand massage on hand function and grip strength in rheumatoid arthritis patients: a randomized controlled pilot study.
    Rheumatol Int. 2026;46:74.
    PubMed     Abstract available
    
    
    
58. YEMESHEV Y, Nurmashev B, Mukhamediyarov M
    Comparative evaluation of large language model-based AI platforms for radiographic assessment in rheumatoid arthritis.
    Rheumatol Int. 2026;46:73.
    PubMed    
    
    
    
59. ANYFANTI P, Antza C, Tragiannidis K, Belancic A, et al
    Sodium and potassium intake in rheumatoid arthritis: a systematic review of clinical studies with implications for disease-related outcomes.
    Rheumatol Int. 2026;46:69.
    PubMed     Abstract available
    
    
    March 2026
60. CROMIE DAJ, Stewart SK, Wright GD, Healy EG, et al
    Correction to: Rheumatoid vasculitis presenting in the absence of rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2026;46:64.
    PubMed    
    
    
    
61. ULST K, Vorobjov S, Laas K, Muller R, et al
    Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.
    Rheumatol Int. 2026;46:61.
    PubMed    
    
    
    
62. OKON A, Makowska J, Brzezinska O
    Beyond anti-SSA and anti-SSB. The clinical significance of new antibodies in the diagnosis of Sjogren disease.
    Rheumatol Int. 2026;46:62.
    PubMed     Abstract available
    
    
    
63. BASTELBERGER J, Clasen M, Geber C, Offenbacher M, et al
    Infrared thermography in the detection of arthritis: a systematic review of diagnostic performance compared with joint ultrasound.
    Rheumatol Int. 2026;46:60.
    PubMed     Abstract available
    
    
    February 2026
64. DURA M, Waszczak-Jeka M
    Selective use of musculoskeletal ultrasound in rheumatoid arthritis: from subclinical inflammation to clinical decision-making.
    Rheumatol Int. 2026;46:50.
    PubMed    
    
    
    
65. SEWERIN P, Kiefer D, Arcq JM, Tsiami S, et al
    Limited discriminatory value of RAMRIS findings between RA and hand osteoarthritis: a cross-sectional MRI study.
    Rheumatol Int. 2026;46:48.
    PubMed     Abstract available
    
    
    
66. BILGIN E, Haznedaroglu IC
    The joint-local renin-angiotensin system in rheumatoid arthritis and osteoarthritis: mechanistic evidence, disease-specific patterns, and translational perspectives.
    Rheumatol Int. 2026;46:43.
    PubMed     Abstract available
    
    
    January 2026
67. SCHLAHT V, Lenzen T, Fellerhoff T, Binder M, et al
    Evaluating usability, adherence and clinical benefit of a new digital heath application in rheumatoid arthritis: a pilot feasibility study.
    Rheumatol Int. 2026;46:30.
    PubMed     Abstract available
    
    
    December 2025
68. ALNAIMAT F, Ghazzal H, Kajjoun G, Kajjoun F, et al
    Cardiovascular rehabilitation in rheumatoid arthritis: evidence and future directions.
    Rheumatol Int. 2025;46:23.
    PubMed    
    
    
    
69. KORKOSZ-WROBEL Z, Telishevska U, Korkosz M, Zarzecka J, et al
    Association between bruxism and inflammatory rheumatic diseases: is there a possible bidirectional relationship?
    Rheumatol Int. 2025;46:22.
    PubMed     Abstract available
    
    
    
70. RYBARCZYK M, Koszela K, Manczak M, Gasik R, et al
    Instability in the distal-to-stabilization segments after occipito-cervical fixation in patients with rheumatoid arthritis: the challenge of spine surgery.
    Rheumatol Int. 2025;46:15.
    PubMed     Abstract available
    
    
    
71. WOLKORTE R, Vonkeman HE, Tuijthof GJM
    Preferences regarding technology to unobtrusively monitor symptoms in rheumatoid arthritis: a qualitative study using focus group discussions.
    Rheumatol Int. 2025;46:13.
    PubMed     Abstract available
    
    
    
72. BAKKER NF, Knoop J, van den Hout WB, Hutting N, et al
    Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial.
    Rheumatol Int. 2025;46:11.
    PubMed     Abstract available
    
    
    
73. HACHOLLI VB, Patil SM, Szeleszczuk L, Prabhanjan BH, et al
    In vitro development and evaluation of chitosan-cellulose nanocrystal microspheres for controlled dexamethasone delivery in rheumatoid arthritis.
    Rheumatol Int. 2025;46:12.
    PubMed     Abstract available
    
    
    
74. FEDKOV D, Peine C, Lang F, Khalil A, et al
    Predictors of adherence to a digital health application in patients with inflammatory arthritis: retrospective analysis.
    Rheumatol Int. 2025;46:16.
    PubMed     Abstract available
    
    
    
75. LOTKOWSKA OD, Adler S, Zgraggen A
    Methotrexate osteopathy in rheumatoid arthritis.
    Rheumatol Int. 2025;46:8.
    PubMed     Abstract available
    
    
    
76. KAHVECI A, Sarikas N
    Determinants and clinical correlates of minor salivary gland biopsy findings for suspected Sjogren disease: a single center retrospective analysis.
    Rheumatol Int. 2025;46:7.
    PubMed     Abstract available
    
    
    
77. JAKUBASZEK M, Kwiatkowska B, Plaza M, Maslinska M, et al
    Platelet count correlates with systemic inflammation but not with synovial vascularity in rheumatoid and psoriatic arthritis: a cross-sectional ultrasound-based study.
    Rheumatol Int. 2025;46:4.
    PubMed     Abstract available
    
    
    November 2025
78. WONG PK, O'Sullivan M, Deng L
    Low influenza, pneumococcal and herpes zoster vaccination coverage in Australian patients commencing a biologic or targeted synthetic disease modifying anti-rheumatic drug for inflammatory arthritis: a nationwide cross-sectional data linkage study.
    Rheumatol Int. 2025;45:273.
    PubMed     Abstract available
    
    
    October 2025
79. MATHIEU S, Riou C, Couderc M, Beauger M, et al
    Smartphone-related pain and discomfort in hand osteoarthritis, rheumatoid arthritis, and psoriatic arthritis: results from the monocentric cross-sectional PHONERIC study.
    Rheumatol Int. 2025;45:258.
    PubMed     Abstract available
    
    
    
80. BLOMBERG E, Wahlin B, Sodergren A
    Comparable area under the curve for three risk scores to detect interstitial lung disease in patients with rheumatoid arthritis: an external validation.
    Rheumatol Int. 2025;45:252.
    PubMed     Abstract available
    
    
    
81. AUSSERWINKLER M, Hueber AJ, Gensluckner S, Paulweber B, et al
    Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study.
    Rheumatol Int. 2025;45:243.
    PubMed     Abstract available
    
    
    
82. AKGOZ A, Yakut Y, Tufekci O, Aktas BE, et al
    Correction: Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical trial.
    Rheumatol Int. 2025;45:245.
    PubMed    
    
    
    September 2025
83. ANIL C, Akaltun MS, Altindag O, Gur A, et al
    Reduced forearm muscle thickness and hand strength in patients with rheumatoid arthritis: an ultrasonographic cross-sectional study.
    Rheumatol Int. 2025;45:238.
    PubMed     Abstract available
    
    
    
84. WILLIAMS JC, Rogers K, Southworth J, Hum RM, et al
    High prevalence and distinct patterns of metabolic syndrome in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a population-based study.
    Rheumatol Int. 2025;45:239.
    PubMed     Abstract available
    
    
    
85. ZEKIC T, Blazic F, Katalinic N, Cizmarevic NS, et al
    Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis-a cross-sectional study.
    Rheumatol Int. 2025;45:236.
    PubMed     Abstract available
    
    
    
86. PATIL H, Prasad S, Subramanian R, Mamadapur M, et al
    Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study.
    Rheumatol Int. 2025;45:235.
    PubMed     Abstract available
    
    
    
87. DUBEY S, Peddasomayajulu A, Nandagudi A, Maw W, et al
    Enhanced education and support needs in rheumatoid arthritis associated interstitial lung disease (RA-ILD) - patient experiences from a multicentre UK survey.
    Rheumatol Int. 2025;45:237.
    PubMed     Abstract available
    
    
    
88. NAKAPHAN P, Pajareya P, Jansem P, Phutinart S, et al
    Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2025;45:232.
    PubMed     Abstract available
    
    
    
89. GULER T, Yurdakul FG, Ataman S, Akgul O, et al
    The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry.
    Rheumatol Int. 2025;45:222.
    PubMed     Abstract available
    
    
    
90. AKGOZ A, Yakut Y, Tufekci O, Aktas BE, et al
    Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical tiral.
    Rheumatol Int. 2025;45:221.
    PubMed    
    
    
    
91. RYBARCZYK M, Koszela K, Manczak M, Gasik R, et al
    Change in the angle of cervical lordosis after occipito-cervical fixation in the course of instability of C1-C2 in patients with rheumatoid arthritis.
    Rheumatol Int. 2025;45:213.
    PubMed     Abstract available
    
    
    August 2025
92. POTOCKA W, Assy Z, van Tilborg MMA, Bikker FJ, et al
    Association between dry mouth and dry eyes: a systematic literature review of clinical evidence.
    Rheumatol Int. 2025;45:209.
    PubMed     Abstract available
    
    
    
93. MIROCHA G, Makowska J, Brzezinska O
    Risk factors of nociplastic pain in patients with autoimmune arthritis: web-based cross-sectional survey of patients.
    Rheumatol Int. 2025;45:205.
    PubMed     Abstract available
    
    
    
94. TORRENTE-SEGARRA V, Huizinga T, Salomon-Escoto K, Da Silva JP, et al
    Biological DMARD survival in rheumatoid arthritis patients in clinical practice: a METEOR registry data analysis.
    Rheumatol Int. 2025;45:190.
    PubMed    
    
    
    
95. NEGRON JB, Lopez-Olivo MA, Carmona L, Christensen R, et al
    The advocacy effect: a grounded theory study on the inclusion of caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritis.
    Rheumatol Int. 2025;45:188.
    PubMed     Abstract available
    
    
    
96. KARADAG DT, Gokcen N, Yazici A, Cefle A, et al
    Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional national survey of Turkish rheumatologists.
    Rheumatol Int. 2025;45:187.
    PubMed     Abstract available
    
    
    
97. NOSSENT JC, Keen HI, Preen DB, Inderjeeth CA, et al
    Epidemiology and complications of rheumatoid arthritis in the Indigenous Australian population.
    Rheumatol Int. 2025;45:185.
    PubMed     Abstract available
    
    
    
98. RUSINOVICH-LOVGACH O, Plaza Z, Fernandez-Castro M, Rosas-Gomez de Salazar J, et al
    High incidence of lymphoma in Sjogren's disease: predictors and mortality implications in a prospective cohort study.
    Rheumatol Int. 2025;45:184.
    PubMed     Abstract available
    
    
    
99. CHEN G, Mansoor M
    Letter to the editor: social determinants of health in managing late-onset rheumatoid arthritis.
    Rheumatol Int. 2025;45:180.
    PubMed    
    
    
    
100. CALVO-ARANDA E, Novella-Navarro M
     Cardiovascular vasculopathy in gout and rheumatoid arthritis: a shared perspective.
     Rheumatol Int. 2025;45:179.
     PubMed    
     
     
     July 2025
101. JAKUBASZEK M, Kwiatkowska B, Plaza M, Maslinska M, et al
     Anti-citrullinated protein antibodies may be prognostic factor for vascularization of the synovial membrane in patients with high activity of RA.
     Rheumatol Int. 2025;45:172.
     PubMed     Abstract available
     
     
     
102. KOCYIGIT BF, Zimba O, Yessirkepov M, Khojakulova U, et al
     Rheumatoid hand massage therapy to mitigate sarcopenia and improve patients' quality of life: a hypothesis.
     Rheumatol Int. 2025;45:173.
     PubMed     Abstract available
     
     
     
103. CROMIE DAJ, Stewart SK, Wright GD, Healy EG, et al
     Rheumatoid vasculitis presenting in the absence of rheumatoid arthritis: a case-based review.
     Rheumatol Int. 2025;45:168.
     PubMed     Abstract available
     
     
     June 2025
104. MURPHY L, Murphy G, Cornally N, McHugh S, et al
     Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice.
     Rheumatol Int. 2025;45:158.
     PubMed     Abstract available
     
     
     
105. FEDORCHENKO Y, Zimba O, Qumar AB, Yessirkepov M, et al
     Physical activity of older patients with rheumatoid arthritis.
     Rheumatol Int. 2025;45:157.
     PubMed     Abstract available
     
     
     
106. FERNANDEZ-CASTRO M, Plaza-Almuedo Z, Rosas J, Martinez-Taboada V, et al
     Long-term changes in Sjogren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.
     Rheumatol Int. 2025;45:156.
     PubMed     Abstract available
     
     
     
107. GAVAN SP, Chang S, Rivellese F, Ide Z, et al
     Estimating pain visual analogue scale from health assessment questionnaire for rheumatoid arthritis with beta mixture models.
     Rheumatol Int. 2025;45:154.
     PubMed     Abstract available
     
     
     
108. ZIMBA O, Baimukhamedov C, Kocyigit BF
     Late-onset rheumatoid arthritis: clinical features, diagnostic challenges, and treatment approaches.
     Rheumatol Int. 2025;45:152.
     PubMed     Abstract available
     
     
     May 2025
109. BRYANT MJ, Lester S, Russell O, Whittle S, et al
     Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients.
     Rheumatol Int. 2025;45:138.
     PubMed     Abstract available
     
     
     
110. LOPEZ C, Parisi S, Parasiliti-Caprino M, Beccuti G, et al
     Disease activity score is associated with vertebral fragility fractures in patients with rheumatoid arthritis: a cross-sectional multidisciplinary study.
     Rheumatol Int. 2025;45:133.
     PubMed     Abstract available
     
     
     April 2025
111. KONAL O, Bolen F, Guvenc TS, Pehlivan O, et al
     Gout and rheumatoid arthritis are associated with subclinical vascular damage, reduced brachial vasoreactivity and coronary microvascular dysfunction: a case-control study.
     Rheumatol Int. 2025;45:117.
     PubMed     Abstract available
     
     
     
112. KIRIK A, Sahin N, Baykul M, Bodur H, et al
     Low vaccination rates and awareness status in patients with rheumatoid arthritis: a nationwide cross-sectional survey study.
     Rheumatol Int. 2025;45:116.
     PubMed     Abstract available
     
     
     
113. BOUR S, Goossens L, Khidir S, de Jong P, et al
     The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis.
     Rheumatol Int. 2025;45:112.
     PubMed     Abstract available
     
     
     
114. ANYFANTI P, Angeloudi E, Pagkopoulou E, Boutel M, et al
     Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.
     Rheumatol Int. 2025;45:111.
     PubMed     Abstract available
     
     
     
115. KARPOUZAS GA, Ormseth SR, Van Riel P, Myasoedova E, et al
     Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study.
     Rheumatol Int. 2025;45:106.
     PubMed     Abstract available
     
     
     
116. ZENGIN ACEMOGLU SS, Bircan AO, Turk I, Coskun Benlidayi I, et al
     Increased fear of falling in primary Sjogren's syndrome: kinesiophobia, impaired balance and poor sleep quality as triggering factors.
     Rheumatol Int. 2025;45:97.
     PubMed     Abstract available
     
     
     
117. RISSER LM, Witte T, Englbrecht M, Strunz PP, et al
     Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
     Rheumatol Int. 2025;45:100.
     PubMed     Abstract available
     
     
     
118. KUSZMIERSZ P, Gula Z, Strach M, Nowakowski J, et al
     Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort.
     Rheumatol Int. 2025;45:96.
     PubMed     Abstract available
     
     
     
119. BENAVENT D, Carmona L, Garcia Llorente JF, Montoro M, et al
     Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review.
     Rheumatol Int. 2025;45:91.
     PubMed     Abstract available
     
     
     
120. SUZUKI K, Akiyama M, Shimanuki K, Kaneko Y, et al
     Radiological extent predicts prognosis and relapse after acute exacerbation of interstitial lung disease in patients with rheumatoid arthritis: KEIO-RA-cohort.
     Rheumatol Int. 2025;45:92.
     PubMed     Abstract available
     
     
     
121. FIERRO JJ, Schoots MH, Liefers SC, der Meer BD, et al
     Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases.
     Rheumatol Int. 2025;45:90.
     PubMed     Abstract available
     
     
     March 2025
122. BRZEZINSKA O, Cieplucha A, Slodkowski K, Lewandowska-Polak A, et al
     The incidence of hypersensitivity to non-steroid anti-inflammatory drugs in the group of patients with rheumatoid musculoskeletal disorders: the cross-sectional study.
     Rheumatol Int. 2025;45:82.
     PubMed     Abstract available
     
     
     
123. KHOJAKULOVA U, Yessirkepov M, Zimba O, Fedorchenko Y, et al
     Massage therapy in rheumatoid arthritis.
     Rheumatol Int. 2025;45:76.
     PubMed     Abstract available
     
     
     February 2025
124. FLOOD M, Ni Gabhann-Dromgoole J, Tynan G, Dillon N, et al
     Use of complementary and alternative medicine (CAM) among people living with Sjogren's: a cross-sectional survey using a modified international CAM questionnaire (I-CAM-Q).
     Rheumatol Int. 2025;45:55.
     PubMed     Abstract available
     
     
     
125. LINDGREN LH, Hammer NM, Flurey CA, Jensen KV, et al
     Gender differences in illness acceptance and coping strategies among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a cross-sectional survey study.
     Rheumatol Int. 2025;45:52.
     PubMed     Abstract available
     
     
     
126. FEDORCHENKO Y, Yessirkepov M, Doskaliuk B, Zaiats L, et al
     Thyroid disease as a comorbidity in inflammatory rheumatic diseases.
     Rheumatol Int. 2025;45:46.
     PubMed     Abstract available
     
     
     
127. BERTHELOT W, Sirois C, Julien AS, Amiable N, et al
     The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.
     Rheumatol Int. 2025;45:44.
     PubMed     Abstract available
     
     
     
128. PFEUFFER N, Hartmann F, Grahammer M, Simon D, et al
     Early detection of rheumatoid arthritis through patient empowerment by tailored digital monitoring and education: a feasibility study.
     Rheumatol Int. 2025;45:43.
     PubMed     Abstract available
     
     
     January 2025
129. GOKCEN N, Komac A, Tuncer Kuru F, Ozdemir Isik O, et al
     Inadequate sleep hygiene as a key factor in poor sleep quality in systemic sclerosis: an observational, cross-sectional study.
     Rheumatol Int. 2025;45:40.
     PubMed     Abstract available
     
     
     
130. POLAK D, Korkosz M, Gula Z
     Sleep disorders in rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis.
     Rheumatol Int. 2025;45:36.
     PubMed     Abstract available
     
     
     
131. JASKOLSKA M, Rytlewska M, Dulak NA, Ulanowski M, et al
     Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.
     Rheumatol Int. 2025;45:35.
     PubMed     Abstract available
     
     
     
132. PRASANNA H, Inderjeeth CA, Nossent JC, Almutairi KB, et al
     The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis.
     Rheumatol Int. 2025;45:34.
     PubMed     Abstract available
     
     
     
133. AUSSERWINKLER M, Gensluckner S, Frey V, Gostner I, et al
     Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study.
     Rheumatol Int. 2025;45:33.
     PubMed     Abstract available
     
     
     
134. SWEENEY M, Carpenter L, de Souza S, Caton E, et al
     Self-management behaviors do not affect remission but mediate between mental health and disease outcomes in a longitudinal study of rheumatoid arthritis.
     Rheumatol Int. 2025;45:31.
     PubMed     Abstract available
     
     
     
135. GULA Z, Krzysciak W, Kuszmiersz P, Bystrowska B, et al
     Higher serotonin levels among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis compared to healthy controls assessed by liquid chromatography-tandem mass spectrometry (LC-MS).
     Rheumatol Int. 2025;45:17.
     PubMed     Abstract available
     
     
     December 2024
136. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
     Discontinuation of biologic and target-specific therapy in patients with rheumatoid arthritis: a retrospective cohort study.
     Rheumatol Int. 2024;45:6.
     PubMed     Abstract available
     
     
     
137. WINTER L, Petzinna SM, Skowasch D, Pizarro C, et al
     Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.
     Rheumatol Int. 2024;45:3.
     PubMed     Abstract available
     
     
     
138. SUZUKI K, Akiyama M, Takei H, Kaneko Y, et al
     Successful rituximab treatment in a seronegative rheumatoid arthritis patient with concurrent cold agglutinin syndrome and immune thrombocytopenia.
     Rheumatol Int. 2024;45:2.
     PubMed     Abstract available
     
     
     
139. BRIX L, Hedemann-Nielsen A, Medrud L, Fredberg U, et al
     Joint swelling in the hand in rheumatoid arthritis: agreement between clinical evaluation, ultrasonography, magnetic resonance imaging and patient self-evaluation.
     Rheumatol Int. 2024;45:1.
     PubMed     Abstract available
     
     
     
140. BOURNIA VK, Fragoulis GE, Mitrou P, Tsolakidis A, et al
     Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.
     Rheumatol Int. 2024;44:2837-2846.
     PubMed     Abstract available
     
     
     
141. XU Z, Han T, Cheng L, Fan J, et al
     The real experience of reporting electronic patient-reported outcomes in patients with inflammatory arthritis and factors influencing participation: a scoping review.
     Rheumatol Int. 2024;44:2795-2806.
     PubMed     Abstract available
     
     
     
142. ANTON J, Mosquera JM, Calzada J, Iglesias E, et al
     Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.
     Rheumatol Int. 2024;44:2911-2920.
     PubMed     Abstract available
     
     
     
143. PRASAD CB, Kopp CR, Naidu G, Sharma V, et al
     Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjogren's syndrome: a systematic review of individual patient data.
     Rheumatol Int. 2024;44:2807-2815.
     PubMed     Abstract available
     
     
     November 2024
144. LEE JS, Oh JS, Kim S, Kim YJ, et al
     The association of obesity and the risk of rheumatoid arthritis according to abdominal obesity status: a nationwide population-based study in Korea.
     Rheumatol Int. 2024 Nov 22. doi: 10.1007/s00296-024-05748.
     PubMed     Abstract available
     
     
     
145. GULA Z, Losinska K, Kuszmiersz P, Strach M, et al
     A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.
     Rheumatol Int. 2024 Nov 11. doi: 10.1007/s00296-024-05740.
     PubMed     Abstract available
     
     
     
146. DEY M, Doskaliuk B, Parodis I, Lindblom J, et al
     COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
     Rheumatol Int. 2024 Nov 6. doi: 10.1007/s00296-024-05742.
     PubMed     Abstract available
     
     
     October 2024
147. UHRENHOLT L, Sorensen MER, Lauridsen KB, Duch K, et al
     Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
     Rheumatol Int. 2024;44:1897-1908.
     PubMed     Abstract available
     
     
     
148. HINKEMA HJ, Westra J, Arends S, Brouwer E, et al
     Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study.
     Rheumatol Int. 2024;44:2007-2016.
     PubMed     Abstract available
     
     
     
149. NIELLY H, Biale L, Gilardin L, Carmoi T, et al
     Tocilizumab-induced psoriatic eruption : a case report and a case-based review.
     Rheumatol Int. 2024;44:2205-2212.
     PubMed     Abstract available
     
     
     September 2024
150. XIE W, Huang H, Geng Y, Fan Y, et al
     Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China.
     Rheumatol Int. 2024 Sep 12. doi: 10.1007/s00296-024-05713.
     PubMed     Abstract available
     
     
     
151. KOSCINSKA-SHUKLA I, Jaskolska M, Chylinska M, Jaskolski D, et al
     Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sjogren syndrome - a prospective observational study on 50 patients.
     Rheumatol Int. 2024;44:1739-1747.
     PubMed     Abstract available
     
     
     
152. DE OLIVEIRA JL, Cordeiro RA, Guedes LKN, Pasoto SG, et al
     Shrinking lung syndrome in primary Sjogren's syndrome: a case-based review.
     Rheumatol Int. 2024;44:1795-1800.
     PubMed     Abstract available
     
     
     August 2024
153. TERMINE M, Davidson Z, Choi T, Leech M, et al
     What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping review.
     Rheumatol Int. 2024 Aug 27. doi: 10.1007/s00296-024-05691.
     PubMed     Abstract available
     
     
     
154. SCHAFER VS, Winter L, Skowasch D, Bauer CJ, et al
     Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study.
     Rheumatol Int. 2024 Aug 21. doi: 10.1007/s00296-024-05685.
     PubMed     Abstract available
     
     
     
155. SAGTAGANOV Z, Bekaryssova D
     Complex rehabilitation of patients with rheumatoid arthritis.
     Rheumatol Int. 2024 Aug 3. doi: 10.1007/s00296-024-05669.
     PubMed     Abstract available
     
     
     July 2024
156. HERMANN S, Palmowski A, Hermann KGA, Muche B, et al
     Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study.
     Rheumatol Int. 2024 Jul 29. doi: 10.1007/s00296-024-05655.
     PubMed     Abstract available
     
     
     
157. MAHAJAN A, Mruthyunjaya P, Padhee S, Ahmed S, et al
     People with osteoarthritis have a higher component of neuropathic pain as compared to those with rheumatoid arthritis: A cross-sectional study.
     Rheumatol Int. 2024 Jul 12. doi: 10.1007/s00296-024-05657.
     PubMed     Abstract available
     
     
     
158. SALEEM RA, Ramadan M, Elshaaer Y, Sukkarieh H, et al
     Laboratory features and pharmacological management of early and late-onset primary Sjogren's syndrome.
     Rheumatol Int. 2024;44:1317-1325.
     PubMed     Abstract available
     
     
     
159. ARYA PVA, Marnet E, Rondla M, Tan JW, et al
     Renal manifestations in adult-onset Still's disease: a systematic review.
     Rheumatol Int. 2024;44:1209-1218.
     PubMed     Abstract available
     
     
     
160. POPOVA V, Geneva-Popova M, Popova-Belova S, Doykov M, et al
     Diagnostic and prognostic role of serum interleukin-6 and carotid ultrasonography to detect subclinical atherosclerosis in patients with RA and ANCA-associated vasculitis.
     Rheumatol Int. 2024;44:1295-1303.
     PubMed     Abstract available
     
     
     
161. BOTABEKOVA A, Baimukhamedov C, Zimba O, Mehta P, et al
     Examining the clinical and radiological landscape of rhupus: navigating the challenges in disease classification.
     Rheumatol Int. 2024;44:1185-1196.
     PubMed     Abstract available
     
     
     
162. FEDORCHENKO Y, Zimba O, Yatsyshyn R, Doskaliuk B, et al
     The interplay between rheumatic diseases and pulmonary health.
     Rheumatol Int. 2024;44:1179-1184.
     PubMed     Abstract available
     
     
     
163. PASOTO SG, Villamarin LEB, de Vinci Kanda Kupa L, Deveza GBH, et al
     Assessment of hydroxychloroquine blood levels in Sjogren's disease patients: drug adherence and clinical associations.
     Rheumatol Int. 2024;44:1305-1315.
     PubMed     Abstract available
     
     
     June 2024
164. SERNA-PENA G, Flores-Gutierrez DP, Vega-Sevilla LF, Villarreal-Saenz MA, et al
     Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional survey.
     Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05648.
     PubMed     Abstract available
     
     
     
165. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D, Suigenbayev D, et al
     Managing rheumatoid arthritis and cardiovascular disease: the role of physical medicine and rehabilitation.
     Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05651.
     PubMed     Abstract available
     
     
     
166. BAKKER NF, van Weely SFE, Boonen A, Vliet Vlieland TPM, et al
     Work-related support for employed and self-employed people with rheumatoid arthritis or axial spondyloarthritis: a cross-sectional online survey of patients.
     Rheumatol Int. 2024 Jun 20. doi: 10.1007/s00296-024-05643.
     PubMed     Abstract available
     
     
     
167. RAMOS-PETERSEN L, Reinoso-Cobo A, Ortega-Avila AB, Garcia-Campos J, et al
     A clinical practice guideline for the management of the foot and ankle in rheumatoid arthritis.
     Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05633.
     PubMed     Abstract available
     
     
     
168. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D
     Yoga as a complementary therapy for rheumatoid arthritis: a case-based review.
     Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05641.
     PubMed     Abstract available
     
     
     
169. CONTRERAS DG, McLane P, Barber CEH, Lin K, et al
     Emergency department utilization by persons with rheumatoid arthritis: a population-based cohort study.
     Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05627.
     PubMed     Abstract available
     
     
     
170. PETZINNA SM, Winter L, Skowasch D, Pizarro C, et al
     Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study.
     Rheumatol Int. 2024;44:1025-1034.
     PubMed     Abstract available
     
     
     May 2024
171. SWEENEY M, Adas MA, Cope A, Norton S, et al
     Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review.
     Rheumatol Int. 2024 May 22. doi: 10.1007/s00296-024-05574.
     PubMed     Abstract available
     
     
     April 2024
172. KRAJEWSKA-WLODARCZYK M, Szelag M, Batko B, Zuber Z, et al
     Rheumatoid arthritis epidemiology: a nationwide study in Poland.
     Rheumatol Int. 2024 Apr 27. doi: 10.1007/s00296-024-05591.
     PubMed     Abstract available
     
     
     
173. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
     Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
     Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
     PubMed     Abstract available
     
     
     
174. LINDGREN LH, de Thurah A, Thomsen T, Hetland ML, et al
     Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
     Rheumatol Int. 2024 Apr 2. doi: 10.1007/s00296-024-05553.
     PubMed     Abstract available
     
     
     
175. FEDORCHENKO Y, Mahmudov K, Abenov Z, Zimba O, et al
     Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs.
     Rheumatol Int. 2024;44:583-591.
     PubMed     Abstract available
     
     
     
176. ASMAR S, Messaykeh J, Hilal N, Rida MA, et al
     Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
     Rheumatol Int. 2024;44:725-736.
     PubMed     Abstract available
     
     
     March 2024
177. GRANT WB
     The present understanding of the effects of dietary red meat and the Mediterranean diet on rheumatoid arthritis.
     Rheumatol Int. 2024 Mar 27. doi: 10.1007/s00296-024-05587.
     PubMed    
     
     
     
178. KALETA K, Krupa J, Suchy W, Sopel A, et al
     Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.
     Rheumatol Int. 2024 Mar 24. doi: 10.1007/s00296-024-05556.
     PubMed     Abstract available
     
     
     
179. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
     Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
     Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
     PubMed     Abstract available
     
     
     
180. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
     Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
     Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
     PubMed     Abstract available
     
     
     
181. LARKIN L, McKenna S, Pyne T, Comerford P, et al
     Promoting physical activity in rheumatoid arthritis through a physiotherapist led behaviour change-based intervention (PIPPRA): a feasibility randomised trial.
     Rheumatol Int. 2024 Mar 4. doi: 10.1007/s00296-024-05544.
     PubMed     Abstract available
     
     
     
182. DURUOZ MT, Nas K, Kasman SA, Oz N, et al
     Validity and reliability of the Duruoz Hand Index in patients with psoriatic arthritis.
     Rheumatol Int. 2024;44:535-542.
     PubMed     Abstract available
     
     
     
183. COSKUN BN, Yagiz B, Ocakoglu G, Dalkilic E, et al
     Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.
     Rheumatol Int. 2024;44:509-515.
     PubMed     Abstract available
     
     
     
184. COX N, Hawarden A, Bajpai R, Farooq S, et al
     The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.
     Rheumatol Int. 2024;44:435-440.
     PubMed     Abstract available
     
     
     
185. KAMINSKI M, Hrycaj P
     Celebrities influence on rheumatic diseases interest: a Google Trends analysis.
     Rheumatol Int. 2024;44:517-521.
     PubMed     Abstract available
     
     
     February 2024
186. SHARMA P, Brown S, Sokoya EM
     Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
     Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
     PubMed     Abstract available
     
     
     January 2024
187. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
     Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
     Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
     PubMed     Abstract available
     
     
     
188. COUREL-IBANEZ J, Vetrovsky T, Ruzickova N, Maranon C, et al
     Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
     Rheumatol Int. 2024 Jan 5. doi: 10.1007/s00296-023-05507.
     PubMed     Abstract available
     
     
     
189. MORALIYSKA R, Georgiev T, Bogdanova-Petrova S, Shivacheva T, et al
     Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
     Rheumatol Int. 2024;44:165-172.
     PubMed     Abstract available
     
     
     December 2023
190. DURUOZ MT, Ataman S, Bodur H, Cay HF, et al
     Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
     Rheumatol Int. 2023 Dec 29. doi: 10.1007/s00296-023-05515.
     PubMed     Abstract available
     
     
     
191. DUBEY S, Woodhead F
     Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
     Rheumatol Int. 2023 Dec 12. doi: 10.1007/s00296-023-05505.
     PubMed     Abstract available
     
     
     
192. BEKARYSSOVA D, Mruthyunjaya Vijaya P, Ahmed S, Sondur S, et al
     Revisiting articular syndrome in the peri-pandemic COVID-19 era.
     Rheumatol Int. 2023;43:2157-2166.
     PubMed     Abstract available
     
     
     
193. BHAT SS, Ahmed S, Reji R, Mehta P, et al
     Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
     Rheumatol Int. 2023;43:2193-2200.
     PubMed     Abstract available
     
     
     November 2023
194. TEUWEN MMH, Vlieland TPMV, van Weely SFE, Schoones JW, et al
     Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.
     Rheumatol Int. 2023 Nov 30. doi: 10.1007/s00296-023-05502.
     PubMed     Abstract available
     
     
     
195. TEUWEN MMH, van Weely SFE, Vliet Vlieland TPM, Douw T, et al
     Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.
     Rheumatol Int. 2023 Nov 25. doi: 10.1007/s00296-023-05487.
     PubMed     Abstract available
     
     
     
196. MIHAYLOVA V, Kazakova M, Batalov Z, Karalilova R, et al
     JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study.
     Rheumatol Int. 2023 Nov 20. doi: 10.1007/s00296-023-05501.
     PubMed     Abstract available
     
     
     
197. DE FIGUEIREDO LQ, de Andrade Lopes FO, Franco AS, Giardini HAM, et al
     Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review.
     Rheumatol Int. 2023 Nov 4. doi: 10.1007/s00296-023-05494.
     PubMed     Abstract available
     
     
     
198. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
     Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
     Rheumatol Int. 2023;43:2057-2064.
     PubMed     Abstract available
     
     
     
199. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
     The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
     Rheumatol Int. 2023;43:2031-2036.
     PubMed     Abstract available
     
     
     October 2023
200. COSKUN BENLIDAYI I
     Exercise therapy for improving cardiovascular health in rheumatoid arthritis.
     Rheumatol Int. 2023 Oct 31. doi: 10.1007/s00296-023-05492.
     PubMed     Abstract available
     
     
     
201. KOUNATIDIS DC, Papadimitropoulos V, Avramidis K, Plenga E, et al
     Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review.
     Rheumatol Int. 2023 Oct 18. doi: 10.1007/s00296-023-05483.
     PubMed     Abstract available
     
     
     
202. FLOURI I, Goutakoli P, Repa A, Bertsias A, et al
     Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
     Rheumatol Int. 2023 Oct 10. doi: 10.1007/s00296-023-05455.
     PubMed     Abstract available
     
     
     
203. THOMSEN T, Aadahl M, Hetland ML, Esbensen BA, et al
     Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
     Rheumatol Int. 2023 Oct 3. doi: 10.1007/s00296-023-05466.
     PubMed     Abstract available
     
     
     September 2023
204. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
     First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis.
     Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05458.
     PubMed     Abstract available
     
     
     
205. SULLI A, Clini P, Bruzzone G, Signori A, et al
     An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
     Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
     PubMed     Abstract available
     
     
     
206. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
     Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
     Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum